Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Incretin-Based Drugs market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Incretin-Based Drugs market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Incretin-Based Drugs market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Incretin-Based Drugs products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Incretin-Based Drugs products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Incretin-Based Drugs market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Incretin-Based Drugs development has been the leading industry trend of Incretin-Based Drugs market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Incretin-Based Drugs Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Glucagon-like peptide-1 receptor (GLP-1) agonists, Dipeptidyl Peptidase-4 (DPP-4) inhibitors, Other |
| By Application Outlook |
Oral Drugs, Injectable Drugs, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
GlaxoSmithKline, Johnson & Johnson, Merck & Co, AstraZeneca, Novartis, Eli Lilly and Company, Boehringer Ingelheim, Takeda Pharmaceutical Company, Sanofi |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- GlaxoSmithKline
- Johnson & Johnson
- Merck & Co
- AstraZeneca
- Novartis
- Eli Lilly and Company
- Boehringer Ingelheim
- Takeda Pharmaceutical Company
- Sanofi
Incretin-Based Drugs Market, By Type
- Glucagon-like peptide-1 receptor (GLP-1) agonists
- Dipeptidyl Peptidase-4 (DPP-4) inhibitors
- Other
Incretin-Based Drugs Market, By Application
- Oral Drugs
- Injectable Drugs
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Incretin-Based Drugs Market Overview
1.1 Incretin-Based Drugs Product Overview
1.2 Incretin-Based Drugs Market Segment by Type
1.2.1 Glucagon-like peptide-1 receptor (GLP-1) agonists
1.2.2 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
1.3 Global Incretin-Based Drugs Market Size by Type
1.3.1 Global Incretin-Based Drugs Sales and Growth by Type
1.3.2 Global Incretin-Based Drugs Sales and Market Share by Type (2017-2020)
1.3.3 Global Incretin-Based Drugs Revenue and Market Share by Type (2017-2020)
1.3.4 Global Incretin-Based Drugs Price by Type (2017-2020)
2 Global Incretin-Based Drugs Market Competition by Company
2.1 Global Incretin-Based Drugs Sales and Market Share by Company (2017-2020)
2.2 Global Incretin-Based Drugs Revenue and Share by Company (2017-2020)
2.3 Global Incretin-Based Drugs Price by Company (2017-2020)
2.4 Global Top Players Incretin-Based Drugs Manufacturing Base Distribution, Sales Area, Product Types
2.5 Incretin-Based Drugs Market Competitive Situation and Trends
2.5.1 Incretin-Based Drugs Market Concentration Rate
2.5.2 Global Incretin-Based Drugs Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Incretin-Based Drugs Company Profiles and Sales Data
3.1 GlaxoSmithKline
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Incretin-Based Drugs Product Category, Application and Specification
3.1.3 GlaxoSmithKline Incretin-Based Drugs Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 Johnson & Johnson
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Incretin-Based Drugs Product Category, Application and Specification
3.2.3 Johnson & Johnson Incretin-Based Drugs Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview
3.3 Merck & Co
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Incretin-Based Drugs Product Category, Application and Specification
3.3.3 Merck & Co Incretin-Based Drugs Sales, Revenue, Price and Gross Margin(2017-2020)
3.3.4 Main Business Overview
3.4 AstraZeneca
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Incretin-Based Drugs Product Category, Application and Specification
3.4.3 AstraZeneca Incretin-Based Drugs Sales, Revenue, Price and Gross Margin(2017-2020)
3.4.4 Main Business Overview
3.5 Novartis
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Incretin-Based Drugs Product Category, Application and Specification
3.5.3 Novartis Incretin-Based Drugs Sales, Revenue, Price and Gross Margin(2017-2020)
3.5.4 Main Business Overview
3.6 Eli Lilly and Company
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Incretin-Based Drugs Product Category, Application and Specification
3.6.3 Eli Lilly and Company Incretin-Based Drugs Sales, Revenue, Price and Gross Margin(2017-2020)
3.6.4 Main Business Overview
3.7 Boehringer Ingelheim
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Incretin-Based Drugs Product Category, Application and Specification
3.7.3 Boehringer Ingelheim Incretin-Based Drugs Sales, Revenue, Price and Gross Margin(2017-2020)
3.7.4 Main Business Overview
3.8 Takeda Pharmaceutical Company
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Incretin-Based Drugs Product Category, Application and Specification
3.8.3 Takeda Pharmaceutical Company Incretin-Based Drugs Sales, Revenue, Price and Gross Margin(2017-2020)
3.8.4 Main Business Overview
3.9 Sanofi
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Incretin-Based Drugs Product Category, Application and Specification
3.9.3 Sanofi Incretin-Based Drugs Sales, Revenue, Price and Gross Margin(2017-2020)
3.9.4 Main Business Overview
4 Incretin-Based Drugs Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Incretin-Based Drugs Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Incretin-Based Drugs Sales and Revenue by Regions
4.2.1 Global Incretin-Based Drugs Sales and Market Share by Regions (2017-2020)
4.2.2 Global Incretin-Based Drugs Revenue and Market Share by Regions (2017-2020)
4.2.3 Global Incretin-Based Drugs Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America Incretin-Based Drugs Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Incretin-Based Drugs Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Incretin-Based Drugs Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Incretin-Based Drugs Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Incretin-Based Drugs Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Incretin-Based Drugs Application/End Users
5.1 Incretin-Based Drugs Segment by Application
5.1.1 Oral Drugs
5.1.2 Injectable Drugs
5.2 Global Incretin-Based Drugs Product Segment by Application
5.2.1 Global Incretin-Based Drugs Sales by Application
5.2.2 Global Incretin-Based Drugs Sales and Market Share by Application (2017-2020)
6 Global Incretin-Based Drugs Market Forecast
6.1 Global Incretin-Based Drugs Sales, Revenue Forecast (2021-2027)
6.1.1 Global Incretin-Based Drugs Sales and Growth Rate Forecast (2021-2027)
6.1.1 Global Incretin-Based Drugs Revenue and Growth Rate Forecast (2021-2027)
6.2 Global Incretin-Based Drugs Forecast by Regions
6.2.1 North America Incretin-Based Drugs Sales and Revenue Forecast (2021-2027)
6.2.2 Europe Incretin-Based Drugs Sales and Revenue Forecast (2021-2027)
6.2.3 Asia-Pacific Incretin-Based Drugs Sales and Revenue Forecast (2021-2027)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Incretin-Based Drugs Sales and Revenue Forecast (2021-2027)
6.2.5 Middle East and Africa Incretin-Based Drugs Sales and Revenue Forecast (2021-2027)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Incretin-Based Drugs Forecast by Type
6.3.1 Global Incretin-Based Drugs Sales and Revenue Forecast by Type (2021-2027)
6.3.2 Glucagon-like peptide-1 receptor (GLP-1) agonists Gowth Forecast
6.3.3 Dipeptidyl Peptidase-4 (DPP-4) inhibitors Gowth Forecast
6.4 Incretin-Based Drugs Forecast by Application
6.4.1 Global Incretin-Based Drugs Sales Forecast by Application (2021-2027)
6.4.2 Global Incretin-Based Drugs Forecast in Oral Drugs
6.4.3 Global Incretin-Based Drugs Forecast in Injectable Drugs
7 Incretin-Based Drugs Upstream Raw Materials
7.1 Incretin-Based Drugs Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Incretin-Based Drugs Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
